Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 20, 2022

Cholestasis and Secondary Sclerosing Cholangitis are Frequent Complications of COVID-19 in Patients With Chronic Liver Disease

Hepatology (Baltimore, Md.)


Additional Info

Hepatology (Baltimore, Md.)
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Hepatology 2022 Dec 01;76(6)1563-1575, L Hartl, K Haslinger, M Angerer, G Semmler, M Schneeweiss-Gleixner, M Jachs, B Simbrunner, DJM Bauer, E Eigenbauer, R Strassl, M Breuer, O Kimberger, D Laxar, K Lampichler, E Halilbasic, AF Stättermayer, A Ba-Ssalamah, M Mandorfer, B Scheiner, T Reiberger, M Trauner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading